Nagoya University, abbreviated to Meidai or NU, is a Japanese national research university located in Chikusa-ku, Nagoya.

During the past decade, Nagoya University conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nagoya University" #1 collaborator was "Epidemiological and Clinical Research Information Network" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Nagoya University" are "Pancreatic Ductal Adenocarcinoma" (2 trials), "Anesthesia" (1 trials), "Mesenteric Approach" (1 trials), "Pancreatic Neoplasms" (1 trials) and "Pancreaticoduodenectomy" (1 trials). Many other conditions were trialed in "Nagoya University" in a lesser frequency.

Most popular intervention types in "Nagoya University" are "Drug" (4 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Endo GIA Reinforced Reload with Tri-Staple technology" (1 trials), "FIRINOX" (1 trials), "Neoadjuvant chemotherapy of gemcitabine plus nab-paclitaxel" (1 trials), "Oral/enteral TJ-100 solution" (1 trials) and "Oral/enteral placebo solution" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nagoya University" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Nagoya University". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Nagoya University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nagoya University, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".